ASST vs. KPTI
ASST (Strive, Inc.) and KPTI (Karyopharm Therapeutics Inc.) are both stocks. ASST operates in Asset Management (Financial Services), while KPTI operates in Biotechnology (Healthcare). Over the past 3 years, ASST returned -53.15%/yr vs -33.06%/yr for KPTI. At a 0.08 correlation, their price movements are largely independent.
Performance
ASST vs. KPTI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ASST achieves a -16.40% return, which is significantly lower than KPTI's 1.49% return.
ASST
- 1D
- 4.05%
- 1M
- -16.90%
- 6M
- -34.92%
- YTD
- -16.40%
- 1Y
- -86.35%
- 3Y*
- -53.15%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -67.29%
KPTI
- 1D
- -21.45%
- 1M
- -17.18%
- 6M
- 18.38%
- YTD
- 1.49%
- 1Y
- 94.03%
- 3Y*
- -33.06%
- 5Y*
- -44.39%
- 10Y*
- -23.26%
- ALL TIME*
- -24.56%
ASST vs. KPTI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
ASST Strive, Inc. | -16.40% | 50.46% | -84.65% | -89.13% |
KPTI Karyopharm Therapeutics Inc. | 1.49% | -27.45% | -21.82% | -75.36% |
Correlation
The correlation between ASST and KPTI is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Feb 3, 2023 | 0.08 |
Fundamentals
ASST:
$1.22B
KPTI:
$169.29M
ASST:
-$19.16
KPTI:
-$11.39
ASST:
77.49
KPTI:
0.85
ASST:
$5.73M
KPTI:
$151.12M
ASST:
-$7.43M
KPTI:
$145.13M
ASST:
-$304.63M
KPTI:
-$93.05M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ASST vs. KPTI — Risk / Return Rank
ASST
KPTI
ASST vs. KPTI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Strive, Inc. (ASST) and Karyopharm Therapeutics Inc. (KPTI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ASST | KPTI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.58 | ||
| Sortino ratioReturn per unit of downside risk | -2.91 | ||
| Omega ratioGain probability vs. loss probability | 0.90 | 1.23 | -0.33 |
| Calmar ratioReturn relative to maximum drawdown | -0.90 | 1.95 | -2.86 |
| Martin ratioReturn relative to average drawdown | -1.05 | 4.87 | -5.92 |
Loading charts...
Drawdowns
ASST vs. KPTI - Drawdown Comparison
The maximum ASST drawdown since its inception was -98.78%, roughly equal to the maximum KPTI drawdown of -99.50%. Use the drawdown chart below to compare losses from any high point for ASST and KPTI.
Loading charts...
Drawdown Indicators
| ASST | KPTI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.78% | -99.50% | +0.72% |
Max Drawdown (1Y)Largest decline over 1 year | -95.98% | -48.36% | -47.62% |
Max Drawdown (3Y)Largest decline over 3 years | -97.25% | -86.96% | -10.29% |
Max Drawdown (5Y)Largest decline over 5 years | — | -98.36% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -99.15% | — |
Current DrawdownCurrent decline from peak | -97.90% | -98.94% | +1.04% |
Average DrawdownAverage peak-to-trough decline | -90.60% | -75.52% | -15.08% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 82.22% | 19.38% | +62.84% |
Volatility
ASST vs. KPTI - Volatility Comparison
The current volatility for Strive, Inc. (ASST) is 25.01%, while Karyopharm Therapeutics Inc. (KPTI) has a volatility of 30.02%. This indicates that ASST experiences smaller price fluctuations and is considered to be less risky than KPTI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ASST | KPTI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.01% | 30.02% | -5.01% |
Volatility (6M)Calculated over the trailing 6-month period | 76.07% | 65.02% | +11.05% |
Volatility (1Y)Calculated over the trailing 1-year period | 147.69% | 95.55% | +52.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 318.38% | 95.60% | +222.78% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 318.38% | 86.76% | +231.62% |
Dividends
ASST vs. KPTI - Dividend Comparison
Neither ASST nor KPTI has paid dividends to shareholders.
Financials
ASST vs. KPTI - Financials Comparison
This section allows you to compare key financial metrics between Strive, Inc. and Karyopharm Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ASST and KPTI have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KPTI has higher volatility (30.02%) compared to ASST (25.01%). In terms of maximum drawdown, ASST dropped -98.78% vs KPTI's -99.50%.
KPTI currently has the higher Sharpe Ratio (0.99 vs -0.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ASST and KPTI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer